Premium Brands Q2 2026 slides: growth targets amid guidance cut

Central government directs state regulators to enhance surveillance over GLP-1 drug promotion. Approved GLP-1 drugs are only for Type 2 diabetes and specific weight management. Advisories were issued to manufacturers and drug controllers regarding product information. Regulators must monitor supply chains and take action against diversion. Advertising platforms will be monitored for non-compliant promotions and…

In Gen Z’s wardrobe, the handloom is no longer reserved for festivals or traditional days at workplaces and colleges. It’s being layered with sneakers, chunky jewellery and spun around with streetwear sensibilities – asserting that heritage is something to own, not just safeguard. On National Handloom Day, designers and Gen Zers share how their reimagining…

Motilal Oswal has begun coverage on Meesho, awarding it a buy rating along with a target price indicating strong potential. The brokerage believes that free cash flow will start manifesting from FY27, highlighting Meesho’s asset-light model as a crucial factor for growth. The company’s recent Q1 performance showed reduced losses and increased marketplace revenue, emphasizing…